Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT01251120
Status:
TERMINATED
Last Update Posted:
2014-11-11
First Post:
2010-11-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-30
First Submit QC Date:
None
Study First Post Date:
2010-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-03
Results First Submit QC Date:
None
Results First Post Date:
2014-11-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-06
Last Update Post Date:
2014-11-11
Last Update Post Date Type:
ESTIMATED